Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alk-Abello, Astrazeneca, Bioarctic, Daiichi, Eisai, Eli Lilly, Immunitybio, Janssen Cilag, Johnson & Johnson, Krystal, Novartis, Outlook, Regeneron, Roche, Vertex.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Biond, Bridgebio, Eisai, GQ Bio Therapeutics, Helix Acquisition, Holling Bio-Pharma, Mustang Bio, Neuren, Nxera, Pacira, Sanofi, Sciclone, Theras.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alumis, Delta-Fly, Nanomerics, Praxis, Virpax.

Biopharmas raising money in public or private financings, including: Innocan.

New hires and promotions in the biopharma industry, including: Garuda, Ovid, Sparingvision.

The top 10 biopharma stock gainers and losers for the week.

A quick look back at top stories.

Year-to-date money raised in public, private and other financings of biopharma companies.